A comparative PET study of [IBF]2-fluoro-2-deoxy-o-glucose (FDG) and [IBF]2-fluoro-2-deoxy o-mannose (FDM) uptake was performed in 13 patients with focal brain lesions. Differences between FDG and FDM with respect to model rate constants, lumped con stant, and estimated metabolic rate for glucose were de termined on a regional basis. Across whole brain, the transport rate constant Kj was almost unchanged, whereas k:J" describing the transport back from tissue to plasma, was 6% higher, and the phosphorylation rate con stant kj was 9% lower for FDM compared to FDG. This eSF]2-fluoro-2-deoxyglucose (FDG) has been used extensively for the quantitative in vivo estima tion with positron emission tomography (PET) of brain glucose metabolism (CMRglc). Modeling the known biochemical pathways of deoxyglucose and glucose in the brain, Sokoloff et al. (1977) and Reiv ich et al. (1979) described an operational equation yielding estimates of local CMRglc from single mea surements of the tracer tissue concentration ap proximately 40 min after injection. This equation requires knowledge of the rate constants for each kinetic step of the compartment model. Further-
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However, in many FDG studies, the radiotracer was not 100% pure FDG. Depending on the radio synthesis, the product contained varying amounts of [lsF]2-fluoro-2-deoxymannose (FDM), some times exceeding 50% (Bida et aI., 1984; Shiue et aI. , 1985) . Because both the rate constants and LC may be different for FDM, the glucose consumption rates determined with impure FDG may be errone ous to some unknown extent. In order to obtain estimates of these errors on a regional basis, we performed, on consecutive days, paired PET stud-ies of the radiotracer uptake in 13 neurological pa tients, using radiochemically pure FDG (Hamacher et aI. , 1986a) and pure FDM (Hamacher et aI. , 1986b ).
METHODS

Mathematical model
The deoxyglucose three-compartment model has been reviewed extensively (Sokoloff et aI., 1977) . It comprises an arterial plasma pool, a precursor tissue pool, and a pool of metabolites in tissue. The same model may be assumed to apply also for deoxymannose. Therefore, the tracer concentration in brain tissue as a function of time t can be expressed in terms of the model rate constants:
where ct(t) is the concentration of tracer in tissue, C� is the concentration of tracer in plasma, and Kj, ki, and kj are the rate constants for inward and outward tissue transport and phosphorylation of FDG or FDM, respec tively. By fitting Eq.
(1) to the tissue radioactivity data re corded dynamically with PET, regional values for the model constants Kj, ki, and kj may be obtained. To im prove the accuracy of the fitting procedure, further rate constants representing the slow process of dephosphory lation, and an additional term for intravascular radioac tivity, may be included in the model.
In its simplest form, the glucose metabolic rate is there fore given by the individual rate constants according to
where Cp is the concentration of glucose in plasma and LC accounts for the differences in transport and phos phorylation between glucose and FDG or FDM, From Eq. (2), it follows that the ratio of the "lumped constants" for FDG and FDM can be derived from the fitted rate constants and from the measured plasma glu cose concentrations:
where the superscripts refer to the FDG and the FDM study, respectively, In most FDG studies, CMRglc is not calculated from dynamic PET series of time activity data but according to an operational equation proposed by Sokoloff et al. (1977) , requiring only a single late scan: Vol, 11, No.3, 1991 CMRglc
where ct is the concentration of tracer in tissue, T is the time interval from injection of FDG to measurement, and K \ , k2, and k3 are average normal values of the FDG rate constants. It has been shown (Wienhard et aI., 1985) that the use of Eq. (4) may produce false results in patholog ical tissue because of major abnormalities of the actual rate constants. These errors may be different for FDG and FDM. Comparison of the ratio of CMRglc calculated according to Eq. (4) for FDM and FDG with the LC ratio [Eq. (3)] provides an error estimate independent of the use of a wrong LC for FDM.
Positron emission tomography
Patients. This comparative study of FDG and FDM was performed in 13 patients (8 women, 5 men; aged 23 to 64 years) suffering from cerebral infarction (2), intracere bral hemorrhage at stage of absorption (5), grade III brain tumor (4), or grade IV brain tumor (2). Each patient was studied twice in random order: eight of them first with FDM and the following day with FDG; with the other five patients, the sequence was reversed. During the 24-h in terval, no appreciable change of clinical status occurred. The patients were comfortably placed on the scanner bed in a room with low ambient light and noise, with eyes closed and ears unoccluded. Approximately 15 min be fore the examination, short catheters were inserted into an antecubital vein for tracer injection and into the con tralateral radial artery for blood sampling.
Tracers and scanning procedure. The radiochemical synthesis of FDG and FDM was described previously (Hamacher et aI., 1986a, b) and is therefore only de scribed in brief: The \ 8F-labeled, O-acetylated precursor of no-carrier-added (n.c.a.) 2-[18F]FDM was produced by aminopolyether-supported nucleophilic fluorination of 1 ,3,4 ,6-tetra-0-acety 1-2-0-trifluoromethanesulfon yl-a-D glucopyranose, the epimeric form of the triflate used for the corresponding 2-e8F]FDG synthesis. The fluorination procedure including the acid hydrolysis and purification of 2-FDM was identical to the FDG synthesis. However, the radiochemical yield was much lower (6%). Isotonic batches of 10-20 mCi of 2-FDM were obtained in a syn thesis time of approximately 1 h. The chemical and radio chemical purity of the n.c.a. 2-FDM was confirmed by HPLC and thin-layer chromatography (TLC) analysis. The specific activities were greater than 2,000 Cilmmol. PET recordings began when the patient received a rapid intravenous bolus injection of 185 MBq (5 mCi) of FDG or FDM in 5 ml of sterile, pyrogen-free normal sa line. Seven equally spaced, parallel planes centered from the canthomeatal line to 81 mm above were simulta neously scanned for 60 min at consecutive intervals grad ually increasing from 1 to 5 min, using a four-ring positron camera (Scanditronix PC 384-7B, Uppsala, Sweden) with a spatial resolution of approximately 8 mm full width at half-maximum in ll-mm slices (Litton et aI., 1984) . This procedure yielded dynamic information about tracer ac cumulation in virtually all major structures of the brain. Data from the tomographic device and from a sample changer used for plasma counting, as well as plasma glu cose values determined in duplicate by a standard enzy matic method, were stored in the memory of a V AX III 780 (Digital, DEC, Maynard, MA, U.S.A.) computer for later processing.
Data analysis
The spatial activity distribution in the scanned planes was reconstructed employing an edge-finding algorithm to determine the skull contour for attenuation correction (Bergstrom et aI., 1982) , a deconvolution for subtraction of scattered radiation (Bergstrom et aI., 1983) , and a fil tered back-projection algorithm, resulting in a 128 x 128 matrix that was displayed as an interpolated 256 x 256 pixel image. Activities measured in tissue and in plasma were corrected for decay and adjusted by cross calibration of the respective counters.
In each tomographic image, relevant anatomical struc tures were outlined as regions of interest (ROIs), using an interactive computer-assisted procedure (Herholz et aI., 1985) . Equation (1) was then fitted to the time-activity data sequentially sampled within each of those regions during the whole scanning period of 60 min, applying a fit stratagem as described previously (Wienhard et aI., 1985) . In addition to the dynamic method, regional activ ities recorded 30 to 40 min after tracer injection were used to compute CMRgJc according to Eq. (4). This is the ear liest time interval where steady-state conditions may commonly be assumed, thus permitting the application of Sokoloffs operational equation.
Prior to further analysis, each patient's ROI maps from his FDG and FDM study were readjusted using a discrete shift-and-match procedure (Pawlik et aI., 1986) to elimi nate ROIs unpaired due to improper head repositioning. The remaining ROIs were then lumped into 13 topograph ically defined cluster regions in either hemisphere, repre senting only morphologically intact brain. As no system atic asymmetry effects were expected across the patient sample, bihemispheric regional data were averaged. Whole-brain values were obtained as means weighted by each contributing ROJ's size. Differences among regions were assessed using multivariate (Kj, ki, kj) or univari ate (CMRglc) repeated-measures analysis of variance fol lowing ascertainment of normal data distribution of the dependent variable(s) by means of the Box-Cox algo rithm with X2 test (Pawlik, 1988) . A paired version of Fisher's F test was used to test for significant hetero scedasticity. Only p values less than 0. 10 are explicitly reported.
RESULTS
The tracer uptake curves for FOG and FDM in a large cortical area of a typical case are compared in Fig. I . Plotted is the ratio of tissue activity to plasma activity vs. the normalized plasma activity integral. The solid lines are fit curves to the data of the three-rate-constant model. In these Gjedde Patlak plots, the data approach a straight line with a slope equaling Kj kj/(ki + kj). The higher uptake of FOG during the whole accumulation period of 1 h is reflected in the differences of the rate constants for FOG and FDM listed in Table 1 . In two patients, the dynamic curve analysis could not be performed because of head movements during tracer accumu lation. Since variations in plasma glucose concen tration directly affect the values of the rate con stants, and mean Cp was marginally higher (p = 0.0527) during the FOG studies, the observed dif ferences in tracer affinity are conservative esti mates of their true discrepancy. As illustrated in Fig. 2 for whole brain, CMRglc,Dyn was significantly larger (p < 0.002) with FOG than with FDM. This differential effect was related to a significantly het erogeneous (tracer x rate constant interaction, p < 0.05) rate constant response, with ki showing the largest (FDM > FOG) and Kj (FOG> FDM) the smallest change from one tracer to the other. No significant added variance was found for the inter action terms involving morphologically intact brain regions or the lesion. The FDG/FDM ratios of plasma glucose concen trations, of the "lumped constants" calculated ac cording to Eq. (3), and of the metabolic rates ob tained from Eq. (4) using a fixed LC are listed in Table 2 for the whole brain and lesion. While in normal brain tissue the variance of the ratios of CMRglc was only 38% larger than the variance of the respective LC ratios, in the lesion area, there was a significant (p < 0.0001) added variance com ponent (+ 210%) in the Sokoloff metabolic ratios compared to the LC ratios, indicating that serious errors are introduced into metabolic estimates, when standard rate constants determined in healthy subjects are falsely used in glucose metabolic quan titation of abnormal brain tissue. Table 3 compares the regional mean values of CMRglc.Sok calculated from the FOG and FDM studies, using a common LC of 0.42 and standard rate constants for FOG.
The metabolic FDG/FDM ratios showed no signif icant differences among regions. They rather sug- gested a single common correction factor of 1,26 to obtain true glucose metabolic estimates from pure FDM data.
DISCUSSION
Fundamental to the deoxyglucose model (Sokoloff et al., 1977) is the steady-state rate of 2deoxyglucose phosphorylation by hexokinase, the first step in glycolysis. This net rate of 2deoxyglucose phosphorylation is translated into the net rate of glucose phosphorylation by division with a correction factor, the "lumped constant," which equals the ratio between the net phosphorylation rates in steady state. As illustrated in Fig. 1 , the time-activity curves for FDM and FDG look very similar and the quality of fit to the data of Eq. (1) was equally good, thus indicating that the Sokoloff model may be rightfully applied to FDM. However, as demonstrated in this study, the model rate con stants of FDM differ from those of FDG. Therefore, the use of FDG contaminated with significant amounts of FDM is bound to yield false low values for CMRglc because of different enzyme affinities of the two tracers. This has not been investigated in humans so far, although numerous FDG studies used impure FDG. A single study performed on three baboons (Braun et al., 1988) yielded system atic decreases by 8, 21, and 22% in the metabolic rates estimated using FDM compared to FDG.
Those authors also reported increased values of Kt and k! for FDM in each case. Our finding of a FDG/ FDM ratio of CMRglc of approximately 1. 25 is in good agreement with their metabolic results. How ever, for the average Kt, only a 2% difference be tween tracers was observed in the present series (Table 1) , while changes were larger in k! and kj.
Generally, values of individual rate constants are subject to much larger estimation errors than those for CMRglc• Therefore, a robust fitting procedure, like the one used here, that is not too sensitive to experimental uncertainties is a prerequisite for the comparison of rate constants from different studies.
Since rate constants vary with plasma glucose con centration, only measurements with unchanged plasma glucose levels are truly comparable. How ever, as can be seen from Eq.
(2), the product Cp tive to changes of plasma glucose concentration, and Kj and k! vary in opposite directions. In this series, the average plasma glucose concentration was lower by 6% during the FDM studies. This may have had little influence on the rate constants, e.g.,
for Kj a 3% increase and for the other rate con stants an even smaller effect may be assumed. In any case, the difference in plasma glucose levels would have tended to minimize rather than to ex aggerate discrepancies in rate constants.
fully ascribed to differences in their respective "lumped constants." The described nonuniform changes of the rate constants for FDG and FDM resulted in a 20% smaller apparent CM R glc for FDM, independent of the sequence of the paired studies. This implies that the lumped constant is 20% lower for FDM than it is for FDG. Consequently, glucose metabolic rates determined with FDG contaminated by up to 55% FDM may underestimate the true glucose consump tion rate by more than 10%. If the degree of impu rity, i. e., the proportion (R) of FDM contained in the injected tracer mixture (FDX), is known, it can easily be corrected for by using an appropriately adjusted global LC FD X :
LC FD X = (l -0.2R)LC FDG (5) In addition to errors arising from the use of a wrong LC, major uncertainties may also be introduced by inappropriate standard rate constants in the Sokoloff operational equation [Eq. (4)]. Table 2 clearly demonstrates that, in individual brain le sions, there are outliers resulting from the sensitiv ity of the operational equation to the discrepancy between actual and average rate constants. In nor mal brain tissue, however, there is little additional variance due to the shortcomings of Eq. (4), and therefore the average FDG/FDM ratios of CM R glc were identical for the dynamic and the static meth ods.
Significant regional variability of the FDG/FDM ratio was not observed (Table 3) , nor was there any major difference between the lesion and its contra lateral control region, thus supporting the view that the differential behavior of FDG and FDM may be
